围手术期抗生素预防用药时长是否影响乳腺癌患者植入物乳房再造术后手术部位感染发生率?一项回顾性研究
该回顾性研究纳入2011年1月至2018年12月间240例接受即刻植入物乳房再造的乳腺癌患者,比较围手术期抗生素预防用药≤24小时与>24小时两组的手术部位感染发生率。按预设多元逻辑回归模型校正风险因素后,≤24小时组不劣于>24小时组,风险差异单侧95%CI上限为9.4%,低于预设的非劣效界值10%,达到统计学显著性。结论认为短疗程(≤24小时)与手术部位感染率增加无关。
要点
- 240例即刻植入物乳房再造患者中,按CDC标准定义的手术部位感染发生率为25.8%。
- 校正风险因素后,围手术期抗生素≤24小时不劣于>24小时,风险差异单侧95%CI上限9.4%,低于预设非劣效界值10%。
- 手术部位感染的风险因素包括肥胖和术后伤口并发症。
核心结论
- 研究发现短疗程围手术期抗生素预防用药(≤24小时)与术后手术部位感染率增加无关。
- 作者认为短疗程可帮助减少副作用和抗菌药物耐药的发生,并与延长围手术期抗生素预防用药同样有效地预防手术部位感染。
研究设计与样本
- 描述性回顾性分析,纳入2011年1月至2018年12月间接受即刻植入物乳房再造的乳腺癌患者240例。
- 比较围手术期抗生素预防用药>24小时与≤24小时两组术后手术部位感染发生率。
主要发现
- 两组间无相关的流行病学、临床或组织病理学差异。
- 按美国疾病控制与预防中心(CDC)标准定义的手术部位感染发生率为25.8%。
- 经预设多元逻辑回归模型校正风险因素后,围手术期抗生素预防用药≤24小时不劣于>24小时。
- 风险差异的单侧95%置信区间上限为9.4%,低于预设的非劣效界值10%,达到统计学显著性。
- 手术部位感染的风险因素包括肥胖和术后伤口并发症。
关键数值与推荐
- 非劣效界值为10%。
- 风险差异单侧95%置信区间上限为9.4%。
- 证据等级:治疗性,III级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative antibiotic prophylaxis is an established concept to reduce the risk of surgical-site infections; however, the optimal treatment duration in prosthetic breast reconstruction is still controversial. This study evaluated a potential association between the perioperative antibiotic prophylaxis duration (≤24 hours versus >24 hours) and incidence of postoperative surgical-site infections in immediate implant-based breast reconstruction in breast cancer patients. METHODS: A descriptive, retrospective analysis of surgical-site infections after immediate implant-based breast reconstruction in breast cancer patients between January of 2011 and December of 2018 was performed. The incidence of postoperative surgical-site infections in patients with more than 24 hours of perioperative antibiotic prophylaxis was compared to patients treated for 24 hours or less. RESULTS: A total of 240 patients who met criteria were included. There were no relevant epidemiologic, clinical, or histopathologic differences between groups. Surgical-site infections as defined by the Centers for Disease Control and Prevention criteria occurred in 25.8 percent. A risk factor-adjusted analysis by a prespecified multiple logistic regression model showed that 24 hours or less of perioperative antibiotic prophylaxis was not inferior to treatment for more than 24 hours. The upper limit of the one-sided 95 percent confidence interval of the risk difference was 9.4 percent (below the prespecified noninferiority margin of 10 percent leading to statistical significance). Risk factors for a surgical-site infection included obesity and postoperative wound complications. CONCLUSIONS: The study found no association between short-course perioperative antibiotic prophylaxis (≤24 hours) and an increased rate of postoperative surgical-site infection. This is of high clinical relevance because short-course treatment can help reduce side effects and the emergence of antimicrobial resistance and prevent surgical-site infections as effectively as a prolonged perioperative antibiotic prophylaxis course. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Rothe K, Münster N, Hapfelmeier A, et al. Does the Duration of Perioperative Antibiotic Prophylaxis Influence the Incidence of Postoperative Surgical-Site Infections in Implant-Based Breast Reconstruction in Women with Breast Cancer? A Retrospective Study. Plast Reconstr Surg. 2022. PMID: 35103626. doi:10.1097/PRS.0000000000008900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。